Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 1/2
×
bempegaldesleukin
×
Genitourinary
×
Clear all
Filters
3
NCT03548467
2023-04-21
DIRECT-01
Nykode Therapeutics ASA
Phase 1/2
Completed
41 enrolled
NCT02983045
2023-03-13
PIVOT-02
Nektar Therapeutics
Phase 1/2
Completed
557 enrolled
22 charts
NCT03435640
2023-03-08
REVEAL
Nektar Therapeutics
Phase 1/2
Terminated
64 enrolled
22 charts